Orient EuroPharma Co., Ltd. (TPEX: 4120)
Taiwan
· Delayed Price · Currency is TWD 48.10
+0.90 (1.91%)
Dec 20, 2024, 1:30 PM CST
Orient EuroPharma Revenue
Orient EuroPharma had revenue of 1.07B TWD in the quarter ending September 30, 2024, a decrease of -2.54%. This brings the company's revenue in the last twelve months to 4.47B, down -4.12% year-over-year. In the year 2023, Orient EuroPharma had annual revenue of 4.59B, down -2.93%.
Revenue (ttm)
4.47B
Revenue Growth
-4.12%
P/S Ratio
0.93
Revenue / Employee
13.19M
Employees
339
Market Cap
4.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.59B | -138.56M | -2.93% |
| Dec 31, 2022 | 4.73B | -36.57M | -0.77% |
| Dec 31, 2021 | 4.77B | -616.63M | -11.45% |
| Dec 31, 2020 | 5.38B | -709.60M | -11.65% |
| Dec 31, 2019 | 6.09B | 583.08M | 10.58% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition